Gout: one year in review 2023.
Leonardo Punzi1, Paola Galozzi2, Roberto Luisetto3
1Centre for Gout and Metabolic Bone and Joint Diseases, Ospedale Civile SS. Giovanni e Paolo, Venezia, Italy. punzileonardo@gmail.com.
Clinical and Experimental Rheumatology
|February 2, 2024
Summary
Gout management has advanced with new insights into its pathogenesis and crystal-induced inflammation. These discoveries offer improved strategies for controlling gout flares and related systemic conditions like cardiovascular disease.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Gout is a chronic joint disease characterized by monosodium urate crystal deposition.
- Recent advancements have improved understanding of gout's diagnosis, genetics, pathogenesis, and comorbidities.
- Crystal-induced inflammation plays a key role in gout and associated systemic disorders.
Purpose of the Study:
- To review new insights into gout management.
- To explore novel therapeutic strategies for gout flares and systemic comorbidities.
- To highlight the expanding role of anti-inflammatory agents in managing gout and cardiovascular health.
Main Methods:
- Review of recent scientific literature on gout.
- Analysis of new findings in crystal-induced inflammation mechanisms.
- Evaluation of clinical data on therapeutic interventions.
Main Results:
- New strategies have been identified for better gout and flare control.
- Understanding crystal-induced inflammation opens avenues for managing systemic diseases.
- Colchicine shows promise beyond gout, with FDA approval for cardiovascular event prevention.
Conclusions:
- Recent progress offers improved gout management and flare control.
- Novel therapeutic approaches target crystal-induced inflammation for systemic benefits.
- Colchicine exemplifies the potential of repurposed anti-inflammatory drugs for cardiovascular protection.
Related Concept Videos
01:23Gastritis III: Clinical Manifestations and Management
252
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
252
01:27Gastritis-I: Introduction and Types
427
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
427
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
86
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
86
01:27Acute Pancreatitis I: Introduction
364
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
364
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
01:29Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92